EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity

Mitchell B. Liester, Bertrand Liang, Laurent Schwartz

Journal of Neurology Research · 2026-09 · 16 (3) · 127-140

DOI: 10.14740/jnr1115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology Research, 2026-09. Verfasst von Mitchell B. Liester und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liester, M. B., Liang, B., & Schwartz, L. (2026). The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity. Journal of Neurology Research, 16(3), 127-140. https://doi.org/10.14740/jnr1115

Vancouver

Liester MB, Liang B, Schwartz L. The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity. Journal of Neurology Research. 2026;16(3):127-140. doi:10.14740/jnr1115

BibTeX
@article{Liester2026,
  author = {Liester, Mitchell B. and Liang, Bertrand and Schwartz, Laurent},
  title = {The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity},
  journal = {Journal of Neurology Research},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {127--140},
  doi = {10.14740/jnr1115}
}
Kostenlos starten →